Daiwa Securities Group
PCVX icon

Daiwa Securities Group’s Vaxcyte PCVX Stock Holding History

Daiwa Securities Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.17M Buy
20,476
+11,362
+125% +$662K ﹤0.01% 776
2026
Q2 		$530K Sell
9,114
-230
-2% -$12.5K ﹤0.01% 956
2026
Q1 		$543K Sell
9,344
-739
-7% -$40.1K ﹤0.01% 894
2025
Q4 		$465K Buy
10,083
+369
+4% +$16.5K ﹤0.01% 893
2025
Q3 		$350K Sell
9,714
-324
-3% -$10.7K ﹤0.01% 931
2025
Q2 		$326K Buy
10,038
+6,205
+162% +$203K ﹤0.01% 913
2025
Q1 		$144K Buy
3,833
+30
+0.8% +$2.4K ﹤0.01% 958
2024
Q4 		$311K Sell
3,803
-91
-2% -$9.04K ﹤0.01% 907
2024
Q3 		$445K Hold
3,894
– – ﹤0.01% 871
2024
Q2 		$294K Sell
3,894
-4
-0.1% -$272 ﹤0.01% 921
2024
Q1 		$266K Buy
3,898
+12
+0.3% +$831 ﹤0.01% 940
2023
Q4 		$244K Buy
3,886
+3,568
+1,122% +$185K ﹤0.01% 923
2023
Q3 		$16K Hold
318
– – ﹤0.01% 1108
2023
Q2 		$16K Hold
318
– – ﹤0.01% 1116
2023
Q1 		$12K Hold
318
– – ﹤0.01% 1100
2022
Q4 		$15K Buy
318
+139
+78% +$5.46K ﹤0.01% 1092
2022
Q3 		$4K Hold
179
– – ﹤0.01% 1179
2022
Q2 		$4K Hold
179
– – ﹤0.01% 1185
2022
Q1 		$4K Hold
179
– – ﹤0.01% 1198
2021
Q4 		$4K Hold
179
– – ﹤0.01% 1224
2021
Q3 		$5K Buy
179
+83
+86% +$2.01K ﹤0.01% 1179
2021
Q2 		$2K Hold
96
– – ﹤0.01% 1149
2021
Q1 		$2K Hold
96
– – ﹤0.01% 1154
2020
Q4 		$3K Buy
+96
New +$3.57K ﹤0.01% 1094

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Daiwa Securities Group's PCVX Position: Q3 2026 in Review

Daiwa Securities Group increased its Vaxcyte (PCVX) stake by 125% in Q3 2026, buying an estimated $662K and bringing the position to 20,476 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Daiwa Securities Group first reported a position in PCVX in Q4 2020 and has held it in 24 quarters since. 238 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Daiwa Securities Group held 20,476 shares of Vaxcyte worth $1.17M as of Q3 2026.
  • Daiwa Securities Group bought 11,362 Vaxcyte shares in Q3 2026, an estimated $662K.
  • Vaxcyte made up ﹤0.01% of Daiwa Securities Group's portfolio in Q3 2026, its #776 holding.
  • Daiwa Securities Group first reported a position in Vaxcyte in Q4 2020 and has held it in 24 quarters since.
  • 238 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.